- Raised $1M funding round, Sep 2019
- Raised $950k funding round, Oct 2017
About
Bioimmunate is a medical device company that offers a precision blood filtering medical technology for select autoimmune diseases. The companys platform technology is initially focused on the treatment of patients with multiple sclerosis (MS). Brain damage from MS is caused by specific MS-related cells that migrate from the blood to the brain. Bioimmunate has developed unique biological filters anchored inside special particles that are able to recognize, capture, and remove these harmful cells from the patients blood before they reach the central nervous system. Bioimmunate is dedicated to improving the quality of life of patients with autoimmune diseases, seeking to provide safer, more cost-effective therapies without side effects. The companys main R&D lab is located at the BioGiv Center at the Hebrew University in Jerusalem.
Funding history · 2 rounds · $1.9M total
Q&A
- What is Bioimmunate Technologies' primary focus?
- Bioimmunate Technologies is a medical device company focused on developing precision blood filtering technology for select autoimmune diseases, with an initial focus on treating multiple sclerosis (MS) patients.
- Where is Bioimmunate Technologies headquartered?
- Bioimmunate Technologies is headquartered in Jerusalem, Israel.
- When was Bioimmunate Technologies founded?
- Bioimmunate Technologies was founded in July 2014.
- How many employees does Bioimmunate Technologies have?
- Bioimmunate Technologies has 1-10 employees.
- What is Bioimmunate Technologies' total funding to date?
- Bioimmunate Technologies has raised a total of $1,950,000.
- When was Bioimmunate Technologies' last funding round?
- Bioimmunate Technologies' last funding round occurred in September 2019.
- What is the core technology developed by Bioimmunate Technologies?
- Bioimmunate Technologies has developed unique biological filters anchored inside special particles that recognize, capture, and remove harmful MS-related cells from a patient's blood before they reach the central nervous system.
- What is Bioimmunate Technologies' current product stage?
- Bioimmunate Technologies is currently in the R&D product stage.
- Does Bioimmunate Technologies hold any patents?
- Yes, Bioimmunate Technologies holds 1 patent.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | expireddomains.com/domain/bioimmunate.com |
|---|
Identifiers & details
| Founded | 2014-7 |
|---|---|
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | expireddomains.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|